| 1 | processes | 7,908 |
| 2 | phenomena | 826 |
| 3 | entities | 571 |
| 4 | invasions | 56 |
| 5 | subsystems | 38 |
| 6 | rites | 28 |
| 7 | neurocircuitry | 24 |
| 8 | cyclizations | 8 |
| 9 | metaplasticity | 6 |
| 10 | lombosciatalgia | 5 |
| 11 | bio-molecules | 4 |
| 12 | nsip-like | 4 |
| 13 | immunopotentiators | 3 |
| 14 | down-grade | 2 |
| 15 | meltdowns | 2 |
| 16 | photoautotrophs | 2 |
| 17 | protestors | 2 |
| 18 | reconfigurations | 2 |
| 19 | subproblems | 2 |
| 20 | activities-antioxidant | 1 |
| 21 | apoptosis/proliferation | 1 |
| 22 | cardiotocogramme | 1 |
| 23 | changes.cpt | 1 |
| 24 | criteria-the | 1 |
| 25 | dark-reversible | 1 |
| 26 | discohesion | 1 |
| 27 | effectors.2 | 1 |
| 28 | fractions/structures | 1 |
| 29 | gs≥7 | 1 |
| 30 | hosmolarity | 1 |
| 31 | lysozymuria | 1 |
| 32 | medicine/cochrane | 1 |
| 33 | monitoring.computer-aided | 1 |
| 34 | neo-self-antigen | 1 |
| 35 | osmosensor | 1 |
| 36 | polyvinylformal | 1 |
| 37 | pro-caspase3 | 1 |
| 38 | quadruplicates | 1 |
| 39 | replacement-dose | 1 |
| 40 | scavengers/antioxidants | 1 |
| 41 | strain-core | 1 |
| 42 | stress-factor | 1 |
| 43 | t1-3n1 | 1 |
| 44 | treatments-infliximab | 1 |
| 45 | volume/osmo-regulators | 1 |
| 1 | activities-antioxidant | 1 |
| 2 | apoptosis/proliferation | 1 |
| 3 | bio-molecules | 4 |
| 4 | cardiotocogramme | 1 |
| 5 | changes.cpt | 1 |
| 6 | criteria-the | 1 |
| 7 | cyclizations | 8 |
| 8 | dark-reversible | 1 |
| 9 | discohesion | 1 |
| 10 | down-grade | 2 |
| 11 | effectors.2 | 1 |
| 12 | entities | 571 |
| 13 | fractions/structures | 1 |
| 14 | gs≥7 | 1 |
| 15 | hosmolarity | 1 |
| 16 | immunopotentiators | 3 |
| 17 | invasions | 56 |
| 18 | lombosciatalgia | 5 |
| 19 | lysozymuria | 1 |
| 20 | medicine/cochrane | 1 |
| 21 | meltdowns | 2 |
| 22 | metaplasticity | 6 |
| 23 | monitoring.computer-aided | 1 |
| 24 | neo-self-antigen | 1 |
| 25 | neurocircuitry | 24 |
| 26 | nsip-like | 4 |
| 27 | osmosensor | 1 |
| 28 | phenomena | 826 |
| 29 | photoautotrophs | 2 |
| 30 | polyvinylformal | 1 |
| 31 | pro-caspase3 | 1 |
| 32 | processes | 7,908 |
| 33 | protestors | 2 |
| 34 | quadruplicates | 1 |
| 35 | reconfigurations | 2 |
| 36 | replacement-dose | 1 |
| 37 | rites | 28 |
| 38 | scavengers/antioxidants | 1 |
| 39 | strain-core | 1 |
| 40 | stress-factor | 1 |
| 41 | subproblems | 2 |
| 42 | subsystems | 38 |
| 43 | t1-3n1 | 1 |
| 44 | treatments-infliximab | 1 |
| 45 | volume/osmo-regulators | 1 |
| 1 | t1-3n1 | 1 |
| 2 | effectors.2 | 1 |
| 3 | pro-caspase3 | 1 |
| 4 | gs≥7 | 1 |
| 5 | lombosciatalgia | 5 |
| 6 | lysozymuria | 1 |
| 7 | phenomena | 826 |
| 8 | treatments-infliximab | 1 |
| 9 | monitoring.computer-aided | 1 |
| 10 | down-grade | 2 |
| 11 | criteria-the | 1 |
| 12 | nsip-like | 4 |
| 13 | dark-reversible | 1 |
| 14 | cardiotocogramme | 1 |
| 15 | medicine/cochrane | 1 |
| 16 | strain-core | 1 |
| 17 | replacement-dose | 1 |
| 18 | polyvinylformal | 1 |
| 19 | neo-self-antigen | 1 |
| 20 | discohesion | 1 |
| 21 | apoptosis/proliferation | 1 |
| 22 | osmosensor | 1 |
| 23 | stress-factor | 1 |
| 24 | entities | 571 |
| 25 | bio-molecules | 4 |
| 26 | fractions/structures | 1 |
| 27 | processes | 7,908 |
| 28 | quadruplicates | 1 |
| 29 | rites | 28 |
| 30 | photoautotrophs | 2 |
| 31 | subproblems | 2 |
| 32 | subsystems | 38 |
| 33 | invasions | 56 |
| 34 | reconfigurations | 2 |
| 35 | cyclizations | 8 |
| 36 | meltdowns | 2 |
| 37 | immunopotentiators | 3 |
| 38 | volume/osmo-regulators | 1 |
| 39 | protestors | 2 |
| 40 | scavengers/antioxidants | 1 |
| 41 | activities-antioxidant | 1 |
| 42 | changes.cpt | 1 |
| 43 | neurocircuitry | 24 |
| 44 | metaplasticity | 6 |
| 45 | hosmolarity | 1 |